Intetumumab (CNTO 95) is a humanized monoclonal antibody targeting CD51/alphaV-integrins. Intetumumab is used in the research of pancreatic ductal adenocarcinoma (PDAC)[1].
Molecular Weight:
(145.14 kDa)
Purity:
99.24
CAS Number:
[725735-28-4]
Target:
Integrin
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted